Optimize Topical Drug Delivery with Foam and Whip Formulations
About this webinar
The experience of applying a topical product can influence whether people find it convenient, acceptable and manageable to use. For pharmaceutical and OTC developers, this highlights the importance of aligning formulation and dispensing systems with application needs. This webinar explores how foam and whipped formulation technologies can address topical drug delivery challenges and improve the application experience for patients and consumers.
Drawing on the development of whipped formulation technology, the featured panelist will introduce the original development question: how to combine the convenience of an aerosol with the confidence in coverage associated with a lotion. That question provides a starting point for examining how delivery innovation can address familiar application challenges.
Attendees will gain a practical understanding of formulation structure, gas expansion and dispensing components. The discussion will distinguish the pressure that delivers product from a Bag-on-Valve package from the whipping gas incorporated into the formulation. It will also explain how these elements influence texture, spreading behavior and application experience, highlighting the relationship between formulation design and usability.
The session will explore three application opportunities: rich barrier products, scalp and hair-bearing areas and localized topical treatments. Each example will connect user challenges with formulation and packaging choices, potential application benefits and approaches to evaluation. The discussion will also consider how body area, application effort, residue and after-feel influence topical product development.
Patient adherence will be examined through application barriers that may discourage consistent use. Attendees will learn how to connect usability and sensory attributes to an adherence rationale while distinguishing patient preference, correct application and demonstrated use over time.
The webinar will conclude with a framework for identifying promising Rx and OTC opportunities, defining application needs and selecting evidence to support development.
Register for this webinar to learn how foam and whipped formulation technologies can advance topical drug delivery and address application challenges.
Who should attend
- Formulation Scientists and Pharmaceutical R&D teams developing topical Rx and OTC products
- Drug Delivery, Packaging, CMC and Technical Operations professionals
- Product Innovation, Brand and Lifecycle Management leaders
- Business Development, Technical Sales and Commercialization teams evaluating differentiated topical delivery formats
What you will learn
- How formulation structure, whipping gas and dispensing components work together to create foam and whipped outputs
- Delivery-system choices for application needs across different body areas
- How usability and sensory attributes may address barriers to patient adherence
- A focused prototype comparison and distinguish application benefits from dosing, penetration and adherence claims
Featured Speaker
Scott Carpenter
Scott Carpenter is VP of Marketing and Partner Innovation at Formulated Solutions, where he connects customer needs with formulation, packaging and manufacturing capabilities for pharmaceutical and OTC products. A packaging engineer by background, Scott holds a BSc in Packaging Science from Clemson University and an MBA from Northwestern University. His experience includes leading new product innovation and development teams, as well as mergers and acquisitions initiatives.
As a co-inventor of whipped formulation technology and a business and innovation partner to many of the world’s leading consumer healthcare companies, Scott brings firsthand insight into the technology’s development and potential applications in topical delivery. His perspective combines packaging engineering, commercial strategy and product innovation, with a focus on improving the patient and consumer experience.
Partner for this event
Formulated Solutions
Formulated Solutions is a U.S.-based Contract Development and Manufacturing Organization specializing in advanced non-sterile, small molecule, topical, nasal, and liquid oral dose OTC drugs, medical devices, and consumer healthcare products. With industry-leading expertise across aerosols, semisolids, liquids, and innovative dispensing systems, the company helps partners transform complex ideas into high-quality, FDA-compliant commercial products.
Operating from two U.S. manufacturing sites with redundant capabilities, Formulated Solutions offers exceptional scalability, from tens of thousands to tens of millions of units, ensuring supply reliability even during seasonal spikes or unexpected market shifts. The organization combines strong regulatory support, deep scientific and engineering resources, and a proven track record of developing and improving formulas.
Known for smart, asset-light partnerships, Formulated Solutions enables customers to avoid large capital investments while accelerating development, strengthening quality, and improving speed to market. The company is trusted by top global healthcare brands for its innovation, technical strength, and unwavering commitment to consumer safety and product performance.